Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2019 5
2020 1
2021 6
2022 5
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma.
Burger MC, Forster MT, Romanski A, Straßheimer F, Macas J, Zeiner PS, Steidl E, Herkt S, Weber KJ, Schupp J, Lun JH, Strecker MI, Wlotzka K, Cakmak P, Opitz C, George R, Mildenberger IC, Nowakowska P, Zhang C, Röder J, Müller E, Ihrig K, Langen KJ, Rieger MA, Herrmann E, Bonig H, Harter PN, Reiss Y, Hattingen E, Rödel F, Plate KH, Tonn T, Senft C, Steinbach JP, Wels WS. Burger MC, et al. Among authors: steidl e. Neuro Oncol. 2023 Nov 2;25(11):2058-2071. doi: 10.1093/neuonc/noad087. Neuro Oncol. 2023. PMID: 37148198 Free PMC article.
Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and Categorization.
Urban H, Steidl E, Hattingen E, Filipski K, Meissner M, Sebastian M, Koch A, Strzelczyk A, Forster MT, Baumgarten P, Ronellenfitsch MW, Steinbach JP, Voss M. Urban H, et al. Among authors: steidl e. Front Immunol. 2022 Jan 3;12:798811. doi: 10.3389/fimmu.2021.798811. eCollection 2021. Front Immunol. 2022. PMID: 35046955 Free PMC article.
Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression.
Müller M, Winz O, Gutsche R, Leijenaar RTH, Kocher M, Lerche C, Filss CP, Stoffels G, Steidl E, Hattingen E, Steinbach JP, Maurer GD, Heinzel A, Galldiks N, Mottaghy FM, Langen KJ, Lohmann P. Müller M, et al. Among authors: steidl e. J Neurooncol. 2022 Sep;159(3):519-529. doi: 10.1007/s11060-022-04089-2. Epub 2022 Jul 19. J Neurooncol. 2022. PMID: 35852737 Free PMC article.
Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes.
Steidl E, Langen KJ, Hmeidan SA, Polomac N, Filss CP, Galldiks N, Lohmann P, Keil F, Filipski K, Mottaghy FM, Shah NJ, Steinbach JP, Hattingen E, Maurer GD. Steidl E, et al. Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1956-1965. doi: 10.1007/s00259-020-05114-0. Epub 2020 Nov 26. Eur J Nucl Med Mol Imaging. 2021. PMID: 33241456 Free PMC article.
Retinoencephalopathy with occipital lobe epilepsy in an OPA-1 mutation carrier.
Nass RD, Hansen N, Quesada C, Rüber T, Kornblum C, Zsurka G, Hermann P, Becker A, Gärtner F, Hattingen E, Block W, Steidl E, Elger CE, Surges R, Kunz WS. Nass RD, et al. Among authors: steidl e. Seizure. 2019 Mar;66:1-3. doi: 10.1016/j.seizure.2019.01.029. Epub 2019 Jan 30. Seizure. 2019. PMID: 30738307 Free article. No abstract available.
19 results